September 12, 2006 - A forthcoming article Translating Epoetin Research Into Practice: The Role Of Government And The Use Of Scientific to be published in the September/October 2006 issue of Health Affairs, 25, no. 5 (2006): 1249-1259 found that spending for epoetin is s single largest drug expenditure. MTPPI chronicles the evolution of epoetin policy based on a lack of well- review concludes with broad-based policy recommendations for the newly implemented Medicare Part D program.
This article can be obtained here: Translating Epoetin Research Into Practice: The Role of Government And The Use Of Scientific Evidence
For more information on this article or other EPO-related research activities, visit us at: MTPPI
The Medical Technology and Practice Patterns Institute is an independent non-profit institute whose mission is to provide research services related to safety, clinical effectiveness, patient outcome, cost, and cost effectiveness of new and emerging medical technologies. MTPPI has not received public or private funding for work related to this analysis.